Press-release for stocks for LMDX listed in the nasdaq exchange

Prices are updated after-hours

LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
Published: 2024-01-05 (Crawled : 23:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Published: 2023-12-29 (Crawled : 21:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal
Published: 2023-10-27 (Crawled : 21:00) - globenewswire.com
MEDE | News | $0.51 0% 500

| Email alert Add to watchlist
LMDX | $0.016 -15.0% 130M

LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub
Published: 2023-10-20 (Crawled : 23:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| Email alert Add to watchlist
lung set heart

LumiraDx Reports Second Quarter 2023 Results
Published: 2023-08-24 (Crawled : 12:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -96.1% | O: 4.83% H: 2.33% C: -7.02%
results

LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
Published: 2023-08-16 (Crawled : 20:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -96.0% | O: 5.9% H: 0.33% C: -3.23%
conference financial results

| -95.34% | O: 6.03% H: 18.13% C: -3.82%
distribution group care expansion commercial diagnostics agreement platform

LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test
Published: 2023-06-30 (Crawled : 18:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| Email alert Add to watchlist
fda covid test application

LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
Published: 2023-06-20 (Crawled : 20:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -95.43% | O: 30.46% H: 17.17% C: -2.98%
covid approval rsv

LumiraDx Reports First Quarter 2023 Results
Published: 2023-05-16 (Crawled : 12:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -97.01% | O: 0.06% H: 1.98% C: -4.8%
results

LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -97.02% | O: 9.77% H: 0.0% C: -7.61%
conference financial results

LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -97.35% | O: -2.19% H: 18.64% C: 6.78%
nasdaq

LumiraDx Reports Fourth Quarter and Full Year 2022 Results
Published: 2023-03-21 (Crawled : 13:00) - biospace.com/
LMDX | $0.016 -15.0% 130M

| -98.14% | O: -0.06% H: 6.95% C: 0.0%
year results

| -98.25% | O: 1.64% H: 10.75% C: 0.0%
conference year financial results

LumiraDx to Present at Raymond James Institutional Investors Conference
Published: 2023-03-03 (Crawled : 14:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -98.56% | O: 3.6% H: 0.0% C: -5.22%
conference

LumiraDx Regains Compliance with Nasdaq Continued Listing Requirements
Published: 2023-02-17 (Crawled : 22:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M